Ultimovacs ASA

OSL:ULTI (Norway)   Ordinary Shares
kr 134.80 (-5.07%) Feb 27
At Loss
P/B:
14.13
Market Cap:
kr 4.64B ($ 439.12M)
Enterprise V:
kr 4.34B ($ 411.07M)
Volume:
203.41K
Avg Vol (2M):
107.26K
Also Trade In:
Volume:
203.41K
At Loss
Avg Vol (2M):
107.26K

Business Description

Description
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.
Name Current Vs Industry Vs History
Cash-To-Debt 72.07
Equity-to-Asset 0.85
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.46
9-Day RSI 41.5
14-Day RSI 45.85
6-1 Month Momentum % 89.57
12-1 Month Momentum % 19.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.81
Quick Ratio 6.81
Cash Ratio 6.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.3
Shareholder Yield % -0.06

Financials (Next Earnings Date:2024-05-07)

OSL:ULTI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ultimovacs ASA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -6
Beta 1.19
Volatility % 60.42
14-Day RSI 45.85
14-Day ATR (kr) 7.615674
20-Day SMA (kr) 140.31
12-1 Month Momentum % 19.55
52-Week Range (kr) 67.9 - 178.6
Shares Outstanding (Mil) 34.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ultimovacs ASA Filings

Filing Date Document Date Form
No Filing Data

Ultimovacs ASA Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Ultimovacs ASA Frequently Asked Questions

What is Ultimovacs ASA(OSL:ULTI)'s stock price today?
The current price of OSL:ULTI is kr134.80. The 52 week high of OSL:ULTI is kr178.60 and 52 week low is kr67.90.
When is next earnings date of Ultimovacs ASA(OSL:ULTI)?
The next earnings date of Ultimovacs ASA(OSL:ULTI) is 2024-05-07.
Does Ultimovacs ASA(OSL:ULTI) pay dividends? If so, how much?
Ultimovacs ASA(OSL:ULTI) does not pay dividend.

Press Release

Subject Date
No Press Release